UK Venture Capital funding is facing a challenging environment

The UK venture capital (VC) landscape faced a challenging environment in 2025, with dealmaking momentum slowing both in terms of volume and value compared to the previous year. The total number of VC deals announced in the country declined by around 17% in 2025 compared to 2024, while the corresponding funding value witnessed a year-on-year (YoY) decline of around 3%, according to Global Data, a leading intelligence and productivity platform.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Compared with a 3% YoY decline in overall global deal volume and 31% growth in global value, the contraction indicates that the UK saw a sharper pullback than the broader market. Nevertheless, while the steeper decline in deal volume in the UK points to tighter diligence, the comparatively modest drop in value suggests investors are still backing promising companies, particularly those demonstrating clear routes to profitability and scalable unit economics.”

Some of the notable VC funding rounds announced in the UK in 2025 include $1.1 billion secured by Nscale, $600 million raised by Isomorphic Labs, $500 million secured by Rapyd, $411 million secured by Verdiva Bio, and $350 million secured by PS Miner, among others.

Bose adds: “Despite the setback, the UK continues to remain among the top five markets for VC funding activity globally in terms of both deal volume and value.”

An analysis of GlobalData’s Financial Deals Database revealed that the UK accounted for around 6% share of the total number of VC deals announced globally in 2025, whereas its share of global value stood at around 4%.